KR950703347A - 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate) - Google Patents

이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate) Download PDF

Info

Publication number
KR950703347A
KR950703347A KR1019950701166A KR19950701166A KR950703347A KR 950703347 A KR950703347 A KR 950703347A KR 1019950701166 A KR1019950701166 A KR 1019950701166A KR 19950701166 A KR19950701166 A KR 19950701166A KR 950703347 A KR950703347 A KR 950703347A
Authority
KR
South Korea
Prior art keywords
inositol
triphosphate
antagonizing
oligomers
activity
Prior art date
Application number
KR1019950701166A
Other languages
English (en)
Korean (ko)
Inventor
케네쓰 에이. 스토더만
Original Assignee
스티븐 엘. 네스비트
메렐 다우 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스티븐 엘. 네스비트, 메렐 다우 파마슈티칼스 인크. filed Critical 스티븐 엘. 네스비트
Publication of KR950703347A publication Critical patent/KR950703347A/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
KR1019950701166A 1992-09-28 1993-08-30 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate) KR950703347A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28
US07/952393 1992-09-28
PCT/US1993/008168 WO1994007507A1 (en) 1992-09-28 1993-08-30 Method for antagonizing inositol 1,4,5-triphosphate

Publications (1)

Publication Number Publication Date
KR950703347A true KR950703347A (ko) 1995-09-20

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701166A KR950703347A (ko) 1992-09-28 1993-08-30 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate)

Country Status (13)

Country Link
EP (1) EP0661982A1 (zh)
JP (1) JPH08502068A (zh)
KR (1) KR950703347A (zh)
AU (1) AU670962B2 (zh)
CA (1) CA2145681A1 (zh)
HU (1) HUT70192A (zh)
IL (1) IL107066A (zh)
MX (1) MX9305933A (zh)
NO (1) NO951163L (zh)
NZ (1) NZ256178A (zh)
TW (1) TW260663B (zh)
WO (1) WO1994007507A1 (zh)
ZA (1) ZA936978B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2978995A (en) * 1994-06-30 1996-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for treating cell proliferative disorders by modulating signal transduction
EP0809492A4 (en) 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
US6133319A (en) * 1996-06-27 2000-10-17 Smithkline Beecham Corporation IL-8 receptor antagonists
EP0915651A4 (en) 1996-06-27 2001-10-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
ATE358486T1 (de) * 2000-11-09 2007-04-15 Contrimmune Biotechnology Inc Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
JP2014531425A (ja) 2011-09-02 2014-11-27 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク 肥満の代謝異常を治療するためのCaMKII、IP3R、カルシニューリン、p38、およびMK2/3阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
IL107066A0 (en) 1993-12-28
ZA936978B (en) 1994-04-18
NO951163D0 (no) 1995-03-27
JPH08502068A (ja) 1996-03-05
CA2145681A1 (en) 1994-04-14
WO1994007507A1 (en) 1994-04-14
MX9305933A (es) 1994-04-29
AU4841793A (en) 1994-04-26
HU9500891D0 (en) 1995-05-29
EP0661982A1 (en) 1995-07-12
HUT70192A (en) 1995-09-28
IL107066A (en) 1998-01-04
TW260663B (zh) 1995-10-21
AU670962B2 (en) 1996-08-08
NO951163L (no) 1995-03-27
NZ256178A (en) 1997-03-24

Similar Documents

Publication Publication Date Title
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
NO933482D0 (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
BR9812176A (pt) Antagonista de receptor il-8
ATE347892T1 (de) Verwendung von nmda-antagonisten zur behandlung von schmerzen
KR950703347A (ko) 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate)
DE69705300T2 (de) Cyclopropylalkansäurederivate
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
EA200000682A1 (ru) Новые ацилгуанидиновые производные в качестве ингибиторов резорбции костной ткани и антагонистов витронектиновых рецепторов
MX9203775A (es) Compuestos arilicos biciclicos substituidos, que exhiben actividad antagonista al leucotrieno b4 selectiva.
KR950016725A (ko) 폐 고혈압성 질병을 억제하는 방법
KR950031060A (ko) 골다공증 치료용 약제학적 조성물
RU94045881A (ru) Производные пептидов, способ получения, фармацевтическая композиция, способ лечения
KR960014128A (ko) 5-ht_4 수용체 효능제
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
ES2109509T3 (es) Procedimiento para la preparacion de beta-fenilisoserina y de sus analogos.
DE69317418T2 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN
UA37173C2 (uk) Болюс з пролонованим виділенням активного інгредієнта, спосіб захисту жуйних тварин від зараження гельмінтами, спосіб профілактики аб0 пригнічення, системного контролю зниження або запобігання зараженнь у жуйних тварин, спосіб отримання болюсів
EP0328203A3 (en) [5(6) (1H-azole-1-ylmethyl)benzimidazole] carbamates
AU3231901A (en) Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
BR0009732A (pt) Agentes antifúngicos isolados de pseudomonas syringae
ZA9016B (en) Pharmaceutical formulations
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
KR880002441A (ko) 살균제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application